Clinical Trial Update: Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing individualized vancomycin dosing using a population pharmacokinetic model for severe infections; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Central South University | Conditions: Severe Infection | Phase 4 | Status: RECRUITING